Home
Journal Information
About
Aims and Scope
Editorial Board
Editor in Chief
Open Access
Editorial Office
Editorial Policies
Journal Issues
Current Issue
In Press
All Issues
Contact Us
Create Account
Login
Please don't use dangerous characters
Title
Author
Abstract
Keywords
First Name
Last Name
Search
ISSN
:
2008-5117
eISSN
:
2008-6830
Submit Your Paper
Instructions for Authors
Instructions for Reviewers
Editor in Chief
Editorial Board
Editorial Policies
English Editing Service
Indexing and Abstracting
Archive
Platinum Open Access
This Platinum Open Access journal publishes articles totally free of charge for the authors and provides unrestricted access to the published content through its website and open access repositories such as PubMed Central. All related costs for processing of the manuscripts are sponsored by Tabriz University of Medical Sciences.
Indexing Info
Collaborator of
J Cardiovasc Thorac Res
. 2020;12(3): 222-226. doi:
10.34172/jcvtr.2020.38
PMID:
33123329
PMCID:
PMC7581840
Short Communication
Early results of the Resilia Inspiris aortic valve in the old age patients - a retrospective comparison with the Carpentier Edwards Magna Ease
Magjun Shala
1
, Lars Niclauss
1
,
2
*
Cited by CrossRef: 6
1- Ueyama H, Xie J, Hanzel G, Byku I, Paone G, Grubb K, Devireddy C, Greenbaum A, Babaliaros V, Gleason P. Hemodynamic Comparison of Resilia and Sapien 3/Ultra Transcatheter Heart Valves in Transcatheter Aortic Valve Replacement.
Circ: Cardiovascular Interventions
. 2024;17(1)
[Crossref]
2- Avvedimento M, Giuliani C, Zanuttini A, Mengi S, Mas-Peiro S, Poulin A, Beaupré F, Paradis J, Porterie J, Kalavrouziotis D, Dumont E, Mohammadi S, Côté M, Pibarot P, Rodés-Cabau J. Hemodynamic Performance of the SAPIEN 3 Ultra Resilia Valve: Insights From a Propensity-Matched Analysis.
Journal of the American Society of Echocardiography
. 2024;
[Crossref]
3- D’Onofrio A, Cibin G, Tessari C, Lorenzoni G, Luzi G, Manzan E, Gregori D, Gerosa G. Multicenter, propensity-weighted comparison of stented, rapid-deployment and new-generation aortic valves.
IJC Heart & Vasculature
. 2024;54:101487
[Crossref]
4- Panagides V, Alperi A, Mesnier J, Philippon F, Bernier M, Rodes-Cabau J. Heart failure following transcatheter aortic valve replacement.
Expert Review of Cardiovascular Therapy
. 2021;19(8):695
[Crossref]
5- Sef D, Thet M, Klokocovnik T, Luthra S. Early and mid-term outcomes after aortic valve replacement using a novel tissue bioprosthesis: a systematic review. 2024;65(2)
[Crossref]
6- Ortoleva J, Gonzalez-Ciccarelli L, Kawabori M, Cobey F, Resor C, Shapeton A. Prosthesis-Patient Mismatch after Transcatheter Aortic Valve Replacement: A New Technology With an Old Problem.
Journal of Cardiothoracic and Vascular Anesthesia
. 2021;35(8):2253
[Crossref]
7- El‐Sayed Ahmad A, Giammarino S, Salamate S, Fehske W, Sirat S, Amer M, Bramlage P, Bakhtiary F, Doss M. Clinical performance of a novel bioprosthetic surgical aortic valve in a German high‐volume center.
Journal of Cardiac Surgery
. 2022;37(12):4833
[Crossref]
8- Condello I. Long-term durability and resilient tissue: ‘the future end of valve in valve!’. 2022;61(6):1450
[Crossref]
9- Yamamoto M, Yashima F, Shirai S, Tada N, Naganuma T, Yamawaki M, Yamanaka F, Mizutani K, Noguchi M, Ueno H, Takagi K, Ohno Y, Izumo M, Nishina H, Suzuyama H, Yamasaki K, Nishioka K, Hachinohe D, Fuku Y, Otsuka T, Asami M, Watanabe Y, Hayashida K, OCEAN-TAVI investigators O. Performance and outcomes of the SAPIEN 3 Ultra RESILIA transcatheter heart valve in the OCEAN-TAVI registry. 2024;20(9):579
[Crossref]
10- Bernard J, Georges G, Hecht S, Pibarot P, Clavel M, Babaki S, Kalavrouziotis D, Mohammadi S. Mid-term clinical and echocardiographic results of the INSPIRIS RESILIA aortic valve: a retrospective comparison to the Magna Ease. 2023;37(1)
[Crossref]
11- Malcolm R, Buckley C, Shore J, Stainthorpe A, Marti B, White A, Deckert J, Vernia M, Carapinha J, López-Marco A, Nikolaidis N, Wendler O. An exploratory cost-effectiveness analysis of a novel tissue valve compared with mechanical valves for surgical aortic valve replacement in subgroups of people aged 55–64 and 65+ with aortic stenosis in the UK.
Expert Review of Pharmacoeconomics & Outcomes Research
. 2023;23(9):1087
[Crossref]